Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Hanall Biopharma (009420 KS)
Watchlist
15
Analysis
Health Care
•
South Korea
HANALL BIOPHARMA CO., LTD. manufactures prescription drugs for hospitals. The Company specializes in making oral and non-oral antibiotics and amino-acid infusions.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Samyang Foods
•
29 Sep 2022 12:05
KOSPI 200 Rebalancing: Recent Changes in the Race
This post investigates the recent changes in the upcoming rebalancing of the KOSPI 200 and discusses the resulting passive impacts and trading...
Sanghyun Park
Follow
379 Views
Share
bullish
•
Lotte Confectionery
•
07 Jul 2022 13:18
KOSPI 200 December Rebelancing: Names Currently Close To & Out of Buffer Zone
This post screens the names currently close to and out of the buffer zone at the KOSPI 200's upcoming rebalancing in December for a preemptive...
Sanghyun Park
Follow
422 Views
Share
bullish
•
Cross Asset Strategy
•
10 Apr 2021 16:14
NPS Raises Domestic Equity Allocations
NPS increased the strategic asset allocation (SAA) limit for domestic equities from the current 2% to 3%. As a result of this change, the sale of...
Douglas Kim
Follow
312 Views
Share
bullish
•
HBM Holdings Limited
•
02 Dec 2020 09:36
Harbour Biomed IPO: Positive Thoughts in Brief
This Insight includes a brief analysis of Harbour Biomed and its proposed listing on the HKEX. We like the deal at the price range offered.
Kemp Dolliver, CFA
335 Views
Share
bullish
•
HBM Holdings Limited
•
01 Dec 2020 09:34
Pre-IPO Harbour Biomed (2142.HK) - Don't Ignore The "Hidden Value"
This article analyzed Harbour's core products, team, technology platforms, thoughts on valuation and the "hidden" value that is often easy to be...
Xinyao (Criss) Wang
Follow
319 Views
Share
Previous
1
2
3
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x